Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2006 | 12-2005 | |
| Sales | 2,446 | 1,805 | 0 | 0 | 0 |
| Gross Profit | 2,446 | 1,805 | N/A | N/A | N/A |
| Operating Expenses | 21,360 | 15,636 | 16,353 | 0 | 0 |
| Operating Income | -18,914 | -13,831 | -16,353 | N/A | N/A |
| Other Income | -24,730 | 1,093 | 1,266 | 0 | 0 |
| Pre-tax Income | -43,643 | -12,738 | -15,087 | 0 | 0 |
| Net Income Continuous | -43,643 | -12,738 | -15,087 | N/A | N/A |
| Net Income | $-43,643 | $-12,738 | $-15,087 | $N/A | $N/A |
| EPS Basic Total Ops | -7.36 | -4.73 | -5.40 | N/A | N/A |
| EPS Basic Continuous Ops | -6.95 | -3.83 | -4.53 | N/A | N/A |
| EPS Diluted Total Ops | -7.36 | -4.73 | -5.40 | N/A | N/A |
| EPS Diluted Continuous Ops | -6.95 | -3.83 | -4.53 | N/A | N/A |
| EBITDA(a) | $-18,594 | $-13,420 | $-15,874 | $N/A | $N/A |